Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.24.2.u1
Balance Sheet Components
 6 Months Ended
Jun. 30, 2024
Balance Sheet Components [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2023 and June 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     June 30,  
    2023     2024  
             
Prepaid directors’ and officers’ liability insurance premiums   $ 270       15  
Prepaid preclinical services     3,103       1,665  
Other     325       594  
Total   $ 3,698       2,274  

 

Property, plant and equipment as of December 31, 2023 and June 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     June 30,  
    2023     2024  
             
Leasehold improvements   $     21       21  
Furniture and fixtures     21       21  
Lab Equipment    

-

       26  
Subtotal     42       68  
Less accumulated depreciation     (16 )     (25 )
Net   $ 26       43  

 

Accounts payable as of December 31, 2023 and June 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     June 30,  
    2023     2024  
             
Trade accounts payable   $ 821       1,376  
Credit card liability     18       96  
Total   $ 839       1,472  

 

Accrued liabilities as of December 31, 2023 and June 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     June 30,  
    2023     2024  
             
Accrued labor costs   $ 1,917     $ 978  
Accrued drug development costs     1,034       2,023  
Other     283       121  
Total   $ 3,234     $ 3,122